Japan Carrier Screening Market Size & Outlook, 2023-2030

The carrier screening market in Japan is expected to reach a projected revenue of US$ 6.7 million by 2030. A compound annual growth rate of 10.2% is expected of Japan carrier screening market from 2024 to 2030.
Revenue, 2023 (US$M)
$3.4
Forecast, 2030 (US$M)
$6.7
CAGR, 2024 - 2030
10.2%
Report Coverage
Japan

Japan carrier screening market highlights

  • The Japan carrier screening market generated a revenue of USD 3.4 million in 2023 and is expected to reach USD 6.7 million by 2030.
  • The Japan market is expected to grow at a CAGR of 10.2% from 2024 to 2030.
  • In terms of segment, spinal muscular atrophy was the largest revenue generating medical conditions in 2023.
  • Cystic Fibrosis is the most lucrative medical conditions segment registering the fastest growth during the forecast period.


Carrier screening market data book summary

Market revenue in 2023USD 3.4 million
Market revenue in 2030USD 6.7 million
Growth rate10.2% (CAGR from 2023 to 2030)
Largest segmentSpinal muscular atrophy
Fastest growing segmentCystic Fibrosis
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationSpinal Muscular Atrophy, Cystic Fibrosis, Tay-Sachs, Gaucher Disease, Sickle Cell Disease, Other Medical Conditions
Key market players worldwideMyriad Genetics Inc, Illumina Inc, Thermo Fisher Scientific Inc, Roche Holding AG, Labcorp Holdings Inc, Centogene NV Ordinary Shares, Danaher Corp, Otogenetics, MedGenome, Roche Holding AG ADR


Other key industry trends

  • In terms of revenue, Japan accounted for 0.3% of the global carrier screening market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, India carrier screening market is projected to lead the regional market in terms of revenue in 2030.
  • India is the fastest growing regional market in Asia Pacific and is projected to reach USD 298.0 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Carrier Screening Market Companies

Name Profile # Employees HQ Website

Japan carrier screening market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to carrier screening market will help companies and investors design strategic landscapes.


Spinal muscular atrophy was the largest segment with a revenue share of 35.29% in 2023. Horizon Databook has segmented the Japan carrier screening market based on spinal muscular atrophy, cystic fibrosis, tay-sachs, gaucher disease, sickle cell disease, other medical conditions covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Japan carrier screening market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Japan carrier screening market databook

  • Our clientele includes a mix of carrier screening market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Japan carrier screening market, including forecasts for subscribers. This country databook contains high-level insights into Japan carrier screening market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Japan carrier screening market report size, by medical conditions, 2018-2030 (US$M)

Japan Carrier Screening Market Share, 2023 & 2030 (US$M)

Japan carrier screening market report size, by medical conditions, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more